LDL cholesterol - how low should we go?
Heart Podcast
00:00
Exploring LDL Cholesterol Lowering Therapies and Injection Frequencies
Exploring different LDL cholesterol lowering therapies, this chapter compares the injection frequency of Encliseran to monoclonal antibodies everlochumab and aliroculumab, highlighting Encliseran's twice-a-year injection schedule and similar LDL-lowering effects, offering clinicians diverse options catering to patient preferences and discussing the upcoming Orion IV trial's potential impact on its adoption.
Transcript
Play full episode
